Inductionless or limited shock testing is possible in most patients with implantable cardioverter-defibrillators/cardiac resynchronization therapy defibrillators: Results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation with Implantable Cardioverter-Defibrillator Implantations)

John D. Day, Rahul N. Doshi, Peter Belott, Ulrika Birgersdotter-Green, Mahnaz Behboodikhah, Peter Ott, Kathryn A. Glatter, Serge Tobias, Howard Frumin, Byron K. Lee, John Merillat, Isaac Wiener, Samuel Wang, Harlan Grogin, Sung Chun, Rob Patrawalla, Brian Crandall, Jeffrey S. Osborn, J. Peter Weiss, Donald L. LappeStacey Neuman

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Inductionless or limited shock testing is possible in most patients with implantable cardioverter-defibrillators/cardiac resynchronization therapy defibrillators: Results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation with Implantable Cardioverter-Defibrillator Implantations)'. Together they form a unique fingerprint.

Medicine & Life Sciences